Latest On Thermo Fisher Scientific Inc (TMO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-06-14 05:56 EST | Dividend | A dividend of $0.39 has been announced on May 22, 2024. It will be paid Jul 15, 2024 with an ex-dividend date of Jun 14, 2024. | Neutral |  |
| 2024-03-14 05:58 EST | Dividend | A dividend of $0.39 has been announced on Feb 21, 2024. It will be paid Apr 15, 2024 with an ex-dividend date of Mar 14, 2024. | Neutral | |
| 2023-12-14 04:55 EST | Dividend | A dividend of $0.35 has been announced on Nov 9, 2023. It will be paid Jan 16, 2024 with an ex-dividend date of Dec 14, 2023. | Neutral | |
| 2023-09-14 05:55 EST | Dividend | A dividend of $0.35 has been announced on Jul 13, 2023. It will be paid Oct 13, 2023 with an ex-dividend date of Sep 14, 2023. | Neutral | |
| 2023-06-14 05:55 EST | Dividend | A dividend of $0.35 has been announced on May 24, 2023. It will be paid Jul 14, 2023 with an ex-dividend date of Jun 14, 2023. | Neutral | |
About Thermo Fisher Scientific Inc (TMO):
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Sp read more...ecialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon brands. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
General
- Name Thermo Fisher Scientific Inc
- Symbol TMO
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 80,000
- Last Split Factor3:2
- Last Split Date1996-06-06
- Fiscal Year EndDecember
- IPO Date1978-01-13
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryLife Sciences Tools & Services
- Gic SubIndustryLife Sciences Tools & Services
- Web URLhttp://www.thermofisher.com
Valuation
- Trailing PE 27.93
- Forward PE 21.05
- Price/Sales (Trailing 12 Mt.) 5.7
- Price/Book (Most Recent Quarter) 5.26
- Enterprise Value Revenue 5.98
- Enterprise Value EBITDA 19.08
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $22.03
- Next Year EPS Estimate $20.17
- Next Quarter EPS Estimate $5.21
- Profit Margin 20%
- Operating Margin 24%
- Return on Assets 8%
- Return on Equity 20%
- Revenue 32.22 billion
- Earnings Per Share $15.96
- Revenue Per Share $81.36
- Gross Profit 16.01 billion
- Quarterly Earnings Growth 54.5%
ESG Rating
Highlights
- Market Capitalization 175.53 billion
- EBITDA 10.2 billion
- PE Ratio 37.77
- PEG Ratio 5.86
- Analyst Target Price $563.61
- Book Value Per Share $86.99
Share Statistics
- Shares Outstanding 396.34 million
- Shares Float 392.86 million
- % Held by Insiders 15%
- % Held by Institutions 91.36%
- Shares Short 2.75 million
- Shares Short Prior Month 2.95 million
- Short Ratio 1.52
- Short % of Float 1%
- Short % of Shares Outstanding 1%
Technicals
- Beta 0.79
- 52 Week High $532.02
- 52 Week Low $249.66
- 50 Day Moving Average 473.3
- 200 Day Moving Average 467.2
Dividends
- Forward Annual Dividend Rate $1.04
- Forward Annual Dividend Yield 0.23%
- Payout Ratio 5%
- Dividend Date 2021-04-16
- ExDividend Date 2021-03-15
- Dividend Per Share $0.88
- Dividend Yield 0.24%
Thermo Fisher Scientific Inc (TMO) Dividend Calendar:
Thermo Fisher Scientific Inc pays an annual dividend of $1.04 per share, with a dividend yield of 0.24%.
TMO's last dividend payment was made to shareholders on April 16, 2021.
Thermo Fisher Scientific Inc pays out 5% of its earnings out as a dividend.
Thermo Fisher Scientific Inc (TMO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Thermo Fisher Scientific Inc (TMO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Thermo Fisher Scientific Inc (TMO) Chart:
Thermo Fisher Scientific Inc (TMO) News:
Below you will find a list of latest news for Thermo Fisher Scientific Inc (TMO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Thermo Fisher Scientific Inc (TMO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest TMO Trades:
Thermo Fisher Scientific Inc (TMO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-04 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-04 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-30 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-10-28 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-28 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-21 | 8-K (Current report) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-29 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-14 | 8-K (Current report) | |
| 2020-09-11 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-11 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-10 | 8-K (Current report) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-27 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-27 | 4 (Statement of changes in beneficial ownership of securities) | |
Thermo Fisher Scientific Inc (TMO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Thermo Fisher Scientific Inc (TMO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 15%
Institutional Ownership: 9136%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-02 | MARC N CASPER | Chairman & CEO | Sell | 15,000.00 | 484.09 | 7,261,350.00 | 54,330.00 | |
| 2020-10-27 | MARC N CASPER | Chairman & CEO | Sell | 1,100.00 | 490.04 | 539,044.00 | 211,593.53 | |
| 2020-10-27 | MARC N CASPER | Chairman & CEO | Sell | 2,716.00 | 489.03 | 1,328,205.48 | 212,693.53 | |
| 2020-10-27 | MARC N CASPER | Chairman & CEO | Sell | 1,601.00 | 488.08 | 781,416.08 | 215,409.53 | |
| 2020-10-27 | MARC N CASPER | Chairman & CEO | Sell | 2,499.00 | 487.14 | 1,217,362.86 | 217,010.53 | |
| 2020-10-27 | MARC N CASPER | Chairman & CEO | Sell | 1,484.00 | 486.06 | 721,313.04 | 219,509.53 | |
| 2020-10-27 | MARC N CASPER | Chairman & CEO | Sell | 600.00 | 484.91 | 290,946.00 | 220,993.53 | |
| 2020-10-26 | MARC N CASPER | Chairman & CEO | Sell | 1,615.00 | 481.81 | 778,123.15 | 221,593.53 | |
| 2020-10-26 | MARC N CASPER | Chairman & CEO | Sell | 1,300.00 | 480.54 | 624,702.00 | 223,208.53 | |
| 2020-10-26 | MARC N CASPER | Chairman & CEO | Sell | 4,185.00 | 479.77 | 2,007,837.45 | 224,508.53 | |
| 2020-10-26 | MARC N CASPER | Chairman & CEO | Sell | 2,900.00 | 478.87 | 1,388,723.00 | 228,693.53 | |
| 2020-10-01 | PETER E HORNSTRA | VP & Chief Accounting Officer | Buy | 60.00 | 18,040.00 | | ||
| 2020-08-25 | Mark Stevenson | Executive Vice President & COO | Sell | 22,000.00 | 420.16 | 9,243,520.00 | 34,561.00 | |
| 2020-08-25 | Mark Stevenson | Executive Vice President & COO | Buy | 22,000.00 | 131.07 | 2,883,540.00 | 56,561.00 | |
| 2020-08-24 | Mark Stevenson | Executive Vice President & COO | Sell | 22,000.00 | 429.55 | 9,450,100.00 | 48,621.00 | |
| 2020-08-24 | Mark Stevenson | Executive Vice President & COO | Buy | 22,000.00 | 131.07 | 2,883,540.00 | 70,621.00 | |
| 2020-08-18 | PETER E HORNSTRA | VP & Chief Accounting Officer | Sell | 762.00 | 418.67 | 319,026.54 | 18,212.00 | |
| 2020-08-18 | PETER E HORNSTRA | VP & Chief Accounting Officer | Sell | 1,650.00 | 418.86 | 691,119.00 | 18,212.00 | |
| 2020-08-18 | PETER E HORNSTRA | VP & Chief Accounting Officer | Sell | 925.00 | 418.89 | 387,473.25 | 18,212.00 | |
| 2020-08-18 | PETER E HORNSTRA | VP & Chief Accounting Officer | Buy | 762.00 | 157.68 | 120,152.16 | 18,974.00 | |